June 17th, 2016|
The FDA is investigating claims that popular migraine treatment patch Zecuity® may cause serious side effects such as burns, scars, and damaged skin. The Zecuity® patch is manufactured by Teva Pharmaceuticals and contains the active ingredient sumatriptan, a prescription medication used to treat acute migraine headaches in adults. It. The patch delivery system is designed to deliver a dose of medicine by way of a single-use, battery-powered patch that is wrapped around the upper arm or thigh.
According to the FDA, since marketing of the Zecuity® patch began in September 2015, a large number of patients have reported burns or scars on the skin where the patch was worn. Teva Pharmaceuticals suspended sales, marketing and distribution on June 10, 2016.
Patients reported the following adverse events related to the Zecuity® patch:
- severe redness
- skin discoloration
- cracked skin
If you experienced skin damage as a result of using Zecuity® (sumatriptan) migraine patch, contact Cory Watson Attorneys. Our law firm has recovered more than $2 billion for injury victims nationwide, and we’re available to review your case for free 24 hours a day, 7 days a week. Dial (877) 562-0000.